A Meta-Analysis of Nucleos(t)ide Analogues in Patients with Decompensated Cirrhosis Due to Hepatitis B

被引：0
|
作者：
Yingnan Huang
Hao Wu
Shengdi Wu
Da Fu
Yushui Ma
Xizhong Shen
机构：
[1] Zhongshan Hospital of Fudan University,Department of Gastroenterology
来源：
Digestive Diseases and Sciences | 2013年 / 58卷
关键词：
Hepatitis B; Chronic; Liver cirrhosis; Decompensated; Nucleos(t)ide analogues;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：815 / 823
页数：8
相关论文
共 50 条
  • [21] Comorbidities in chronic hepatitis B patients currently treated with nucleos(t)ide analogues
    Siakavellas, S.
    Goulis, I.
    Manolakopoulos, S.
    Triantos, C.
    Kalliopi, Z.
    Tsentemidou, E.
    Kranidioti, H.
    Zisimopoulos, K.
    Tsoulas, C.
    Dalekos, G.
    Papatheodoridis, G.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S492 - S492
  • [22] Entecavir for Patients with Hepatitis B Decompensated Cirrhosis in China: a meta-analysis
    F.Y. Wang
    B. Li
    Y. Li
    H. Liu
    W.D. Qu
    H.W. Xu
    J.N. Qi
    C.Y. Qin
    Scientific Reports, 6
  • [23] Entecavir for Patients with Hepatitis B Decompensated Cirrhosis in China: a meta-analysis
    Wang, F. Y.
    Li, B.
    Li, Y.
    Liu, H.
    Qu, W. D.
    Xu, H. W.
    Qi, J. N.
    Qin, C. Y.
    SCIENTIFIC REPORTS, 2016, 6
  • [24] Risk Factor Analysis of HCC For Chronic Hepatitis B Patients With Nucleos(t)ide Analogues Therapy
    Yang, Liu-Qing
    Li, Xiang-yong
    Wu, Yuankai
    Chong, Yutian
    HEPATOLOGY, 2012, 56 : 360A - 360A
  • [25] Optimal management of chronic hepatitis B patients receiving nucleos(t)ide analogues
    Buti, Maria
    Roade, Luisa
    Riveiro-Barciela, Mar
    Esteban, Rafael
    LIVER INTERNATIONAL, 2020, 40 : 15 - 21
  • [26] Perspectives on stopping nucleos(t)ide analogues therapy in patients with chronic hepatitis B
    Tout, Issam
    Lampertico, Pietro
    Berg, Thomas
    Asselah, Tarik
    ANTIVIRAL RESEARCH, 2021, 185
  • [27] APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients
    Jia-Horng Kao
    Wen-Juei Jeng
    Qin Ning
    Tung-Hung Su
    Tai-Chung Tseng
    Yoshiyuki Ueno
    Man-Fung Yuen
    Hepatology International, 2021, 15 : 833 - 851
  • [28] Management of chronic hepatitis B patients: efficacy & limitation of nucleos(t)ide analogues
    Inoue, Jun
    Ueno, Yoshiyuki
    Shimosegawa, Tooru
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2011, 133 (01) : 11 - 13
  • [29] Quantitative HBsAg (qHBsAg) as an end point to stop nucleos (t) ide analogues in chronic hepatitis B: a meta-analysis with meta-regression
    Lim, Seng Gee
    Teo, Ada Ee Der
    Chan, Edwin Shih-Yen
    Phyo, Wah Wah
    Chen, David Hsing Yu
    Hargreaves, Carol Anne
    JOURNAL OF HEPATOLOGY, 2022, 77 : S869 - S869
  • [30] Hepatitis B Surface Antigen Seroclearance Rate After Stopping Nucleos(t)ide Analogues in Chronic Hepatitis B-A Systematic Review and Meta-Analysis
    Maung, Soe Thiha
    Decharatanachart, Pakanat
    Chaiteerakij, Roongruedee
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2025,
12345